Concepedia

Victoria Allgood

VA

Statistics

Publications

15

Citations

1.1K

H-Index

14

Active since

1990

Affiliations

University of North Carolina at Chapel Hill(Current)

Baylor College of Medicine

The University of Texas at San Antonio Health Science Center

The University of Texas MD Anderson Cancer Center

University of Wisconsin Carbone Cancer Center

Victoria Allgood is an author at University of North Carolina at Chapel Hill specializing in life sciences, biochemistry, and molecular biology.

Publications per year

1990–2023

15

Publications

15

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

Devalingam Mahalingam, George Wilding, Samuel R. Denmeade et al. · British Journal of Cancer · 2016 · 149 citations · Full text

, , +14

Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid

Corinne M. Silva, Frances E. Powell-Oliver, Christine M. Jewell et al. · Steroids · 1994 · 128 citations

, , +14

Safety and Pharmacokinetic Effects of TNP-470, an Angiogenesis Inhibitor, Combined With Paclitaxel in Patients With Solid Tumors: Evidence for Activity in Non–Small-Cell Lung Cancer

Roy S. Herbst, Timothy Madden, Hai T. Tran et al. · Journal of Clinical Oncology · 2002 · 102 citations

, , +17

Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor.

Victoria Allgood, Robert H. Oakley, John A. Cidlowski · Journal of Biological Chemistry · 1993 · 93 citations · Full text

, , +15

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma

Devalingam Mahalingam, Julio Peguero, Putao Cen et al. · Cancers · 2019 · 89 citations · Full text

, , +16

1–5 of 15